PCSK1N and Alzheimer disease: Therefore, our results converge with post mortem neuropathological evidence [6, 7, 9], pinpointing to αSyn as a key and highly prevalent molecular co-pathology throughout the AD spectrum that can be detected via CSF-based αSyn SAAs.